Neurotez, Inc 991 Highway 22 Category: Biotechnology Products and Services |
Company representatives
Nikolaos Tezapsidis, President & CEO
About Neurotez, Inc
Neurotez is a private company focusing on the discovery and development of safe and efficacious drugs for CNS disorders.
We have used biochemical, molecular & cell biology and in vivo models to screen, identify and characterize suitable candidate biopharmaceuticals targeting major Central Nervous System disorders with unmet medical need.
Dementia is the clinical expression of a multitude of pathological aberrations in the Central nervous System (CNS). The most common pathological substrate in demented elderly is Alzheimer's disease. This CNS disorder is affecting more than 5 million Americans, and 18 million patients worldwide.
Neurotez is focused in the identification and characterization of factors relevant to obesity and/or the metabolic syndrome that modulate brain aging or the conversion of normal brain aging to that hampered with AD.
Products and Services
- Biopharmaceuticals for CNS disorders
Employees
5 to 9
Years In Business
19
Rating
Browse U.S. states for Biotechnology Products and Services
